Loading clinical trials...

Early Stage Retinal Abnormalities in Type 1 Diabetes, Screened With OCT Angiography. | Clinical Trials | Clareo Health

UNKNOWNNCT03496597

Early Stage Retinal Abnormalities in Type 1 Diabetes, Screened With OCT Angiography.

The improvement of imaging techniques in ophthalmology has made it possible to carry out a precise non-invasive study of the retinal microvascular network and to detect early abnormalities in retinal ...

Lead sponsor: Centre Hospitalier Universitaire Dijon•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment520

Start dateFeb 2018

Last updatedMar 10, 2022

Condition

Type 1 Diabetes Patients

Locations shown

CHU Dijon Bourgogne

Dijon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 10, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions